Infectious Diseases – News and Features

Patent Covers Any Chemically Modified siRNA Sequence Used Against the Targeted Gene and Sets Precedent for Sirna Therapeutics' Substantial Target Patent Portfolio in the U.S.

Australian scientists will have a rare opportunity to learn about the future of biomedicine when Nobel Laureate Professor Robert Huber visits Brisbane.

A unique public-private partnership led by researchers at the Broad Institute of MIT and Harvard creates RNAi-based inhibitors for nearly every human and mouse gene.

The strategy might be used to protect animals against influenza or foot-and-mouth disease.

Tecan's Freedom EVO® Workstation has been used to develop automated in vitro selection techniques for identifying and isolating aptamers.

Company has been granted a patent for "Optical detection in a multi-channel bio-separation system."

GE will provide CytoGenix with DNA production reagents for use in the manufacture of vaccines and therapeutic compounds by CytoGenix.

This funding will facilitate continued development of the company's pipeline technologies.

The Bourne Report offers the insightful market analysis available on the emerging use of MEMS and Nanotechnology in medicine.

The article titled 'MicroRNAs as Therapeutic Targets' discusses clinical applications for intervening with microRNAs.